Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence

Detalles Bibliográficos
Autores principales: Khan, Abdul Moiz, Shahnoor, Syeda, Khan, Hareem, Affendi, Marium, Ghaddar, Sawsane Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442090/
https://www.ncbi.nlm.nih.gov/pubmed/37195786
http://dx.doi.org/10.1097/JS9.0000000000000477
_version_ 1785093511116226560
author Khan, Abdul Moiz
Shahnoor, Syeda
Khan, Hareem
Affendi, Marium
Ghaddar, Sawsane Ahmad
author_facet Khan, Abdul Moiz
Shahnoor, Syeda
Khan, Hareem
Affendi, Marium
Ghaddar, Sawsane Ahmad
author_sort Khan, Abdul Moiz
collection PubMed
description
format Online
Article
Text
id pubmed-10442090
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104420902023-08-22 Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence Khan, Abdul Moiz Shahnoor, Syeda Khan, Hareem Affendi, Marium Ghaddar, Sawsane Ahmad Int J Surg Correspondence Lippincott Williams & Wilkins 2023-05-15 /pmc/articles/PMC10442090/ /pubmed/37195786 http://dx.doi.org/10.1097/JS9.0000000000000477 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Correspondence
Khan, Abdul Moiz
Shahnoor, Syeda
Khan, Hareem
Affendi, Marium
Ghaddar, Sawsane Ahmad
Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title_full Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title_fullStr Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title_full_unstemmed Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title_short Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence
title_sort celebrating a breakthrough: the first-ever fda-approved treatment for geographic atrophy: a correspondence
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442090/
https://www.ncbi.nlm.nih.gov/pubmed/37195786
http://dx.doi.org/10.1097/JS9.0000000000000477
work_keys_str_mv AT khanabdulmoiz celebratingabreakthroughthefirsteverfdaapprovedtreatmentforgeographicatrophyacorrespondence
AT shahnoorsyeda celebratingabreakthroughthefirsteverfdaapprovedtreatmentforgeographicatrophyacorrespondence
AT khanhareem celebratingabreakthroughthefirsteverfdaapprovedtreatmentforgeographicatrophyacorrespondence
AT affendimarium celebratingabreakthroughthefirsteverfdaapprovedtreatmentforgeographicatrophyacorrespondence
AT ghaddarsawsaneahmad celebratingabreakthroughthefirsteverfdaapprovedtreatmentforgeographicatrophyacorrespondence

Ejemplares similares